Retrophin, Inc. (RTRX) Enters Into U.S. License Agreement For Thiola® (Tiopronin)
5/30/2014 8:44:51 AM
NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that it has entered into a license agreement with Mission Pharmacal Company, a private company based in San Antonio, Texas, for U.S. marketing rights to Thiola® (tiopronin). Financial terms of the agreement were not immediately disclosed.
Help employers find you! Check out all the jobs and post your resume.
comments powered by